CORDRAN SP Drug Patent Profile
✉ Email this page to a colleague
When do Cordran Sp patents expire, and when can generic versions of Cordran Sp launch?
Cordran Sp is a drug marketed by Almirall and is included in one NDA.
The generic ingredient in CORDRAN SP is flurandrenolide. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the flurandrenolide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cordran Sp
A generic version of CORDRAN SP was approved as flurandrenolide by PADAGIS ISRAEL on August 30th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORDRAN SP?
- What are the global sales for CORDRAN SP?
- What is Average Wholesale Price for CORDRAN SP?
Summary for CORDRAN SP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 50 |
| Patent Applications: | 4,458 |
| DailyMed Link: | CORDRAN SP at DailyMed |
Pharmacology for CORDRAN SP
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for CORDRAN SP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Almirall | CORDRAN SP | flurandrenolide | CREAM;TOPICAL | 012806-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Almirall | CORDRAN SP | flurandrenolide | CREAM;TOPICAL | 012806-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
